Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Larsen KC et al. – The results indicate that optimal immunogenicity may require activation of distinct innate immune signalling pathways. Thus this strategy offers a novel route to the discovery of a new generation of adjuvants.

Related Articles

Progress towards a dengue vaccine
The Lancet Infectious Diseases, 10/27/09    Relevance Score: 68%

Cost-Effectiveness of Human Papillomavirus Vaccination and Cervical Cancer Screening in Women Older Than 30 Years in the United States
Annals of Internal Medicine, 10/21/09    Relevance Score: 67%

Pseudolymphomatous reaction to varicella zoster virus vaccination: role of viral in situ hybridization
Journal of Cutaneous Pathology, 11/06/09    Relevance Score: 64%

HPV: Past, present, and in practice: The Omnia CME Journal
The Journal of Family Practice, 11/02/09    Relevance Score: 64%

Innovation in Cervical Cancer Prevention and Control in Mexico
Archives of Medical Research, 10/26/09    Relevance Score: 64%

Today in Vaccine/Immunotherapy...keeping you current

Response to a Monovalent 2009 Influenza A (H1N1) Vaccine
New England Journal of Medicine, 12/17/09

A Novel Influenza A (H1N1) Vaccine in Various Age Groups
New England Journal of Medicine, 12/17/09

Efficacy and Safety of Pentavalent Human-Bovine Reassortant Rotavirus Vaccine When Administered With Greater Than 10 Weeks Between Doses
The Pediatric Infectious Disease Journal, 12/17/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address